Health Care & Life Sciences » Pharmaceuticals | Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | Ownership

Companies that own Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Norges Bank Investment Management
12,350,000
5.62%
12,350,000
0.01%
06/29/2018
The Vanguard Group, Inc.
6,891,000
3.13%
2,000
0%
07/31/2018
BlackRock International Ltd.
3,942,802
1.79%
62,072
0.28%
09/04/2018
China Southern Asset Management Co., Ltd.
2,076,000
0.94%
2,076,000
0.07%
12/31/2017
BlackRock Japan Co., Ltd.
1,866,400
0.85%
1,711,160
0.01%
09/04/2018
Dimensional Fund Advisors LP
1,042,090
0.47%
38,090
0%
04/30/2018
Société d'Administration et de Gestion Altantas Saga SA
712,000
0.32%
142,000
0.38%
12/31/2017
Parametric Portfolio Associates LLC
652,000
0.3%
0
0%
09/06/2018
Grantham, Mayo, Van Otterloo & Co. LLC
596,000
0.27%
596,000
0.01%
02/28/2018
Allianz Global Investors U.S. LLC
582,000
0.27%
50,000
0%
08/31/2018

About Guangzhou Baiyunshan Pharmaceutical Holdings Co.

View Profile
Address
No. 45 Sha Mian North Street
Guangzhou Guangdong 510130
China
Employees -
Website http://www.gpc.com.cn
Updated 07/08/2019
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern TCM, Great Commerce, and Great Health. The Great Southern TCM segment provides Chinese and Western medicine, chemicals for medicine, natural drugs, biological medicine.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.